Cancer iChart
Published by: Liverpool Drug Interactions Group
Description
Healthcare professionals and patients should use this application to search for potential drug-drug interactions between anti-cancer drugs and other medications. Results are presented as a “Traffic Light” system (red, amber, yellow and green) to indicate the recommendation. A brief summary of each interaction is given along with a grading of the quality of evidence (very low, low, moderate, high). The application is available free of charge and has been developed by Radboudumc in Nijmegen, the Liverpool Drug Interactions Group at the University of Liverpool and Clubzap Ltd.
Requirements: This is an “offline” application that is downloaded to your device. An internet connection is not required to use the application, but is needed for downloading updates.
Why this application may be useful:
Patients with cancer often take medication in addition to cancer therapy either to aid side effects and symptoms, or to treat co-existing conditions. Many of the drug combinations have the potential to interact and this can affect either the patient's safety or the effectiveness of treatment. For this reason some drug combinations should not be given at all, while other drugs may be used together with caution, possibly requiring adjustments to dosage or time of administration. This application is a guide to interactions that may occur between different anti-cancer drugs and other medications that the cancer patient may be prescribed. The application is regularly updated as new data emerge. Full details about the interactions can be found at www.cancer-druginteractions.org
Hide..
Show more..
Requirements: This is an “offline” application that is downloaded to your device. An internet connection is not required to use the application, but is needed for downloading updates.
Why this application may be useful:
Patients with cancer often take medication in addition to cancer therapy either to aid side effects and symptoms, or to treat co-existing conditions. Many of the drug combinations have the potential to interact and this can affect either the patient's safety or the effectiveness of treatment. For this reason some drug combinations should not be given at all, while other drugs may be used together with caution, possibly requiring adjustments to dosage or time of administration. This application is a guide to interactions that may occur between different anti-cancer drugs and other medications that the cancer patient may be prescribed. The application is regularly updated as new data emerge. Full details about the interactions can be found at www.cancer-druginteractions.org
Screenshots
User Rating
App is not rated in Israel yet.
Ratings History
Cancer iChart Installs
Last 30 days
Cancer iChart Revenue
Last 30 daysCancer iChart Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Free
|
|
497
|
Keywords
Cancer iChart Competitors
| Name | Reviews | Recent release | |
|---|---|---|---|
Pharmaceutical Journal
Pharmacy news and learning
|
0
|
3 months ago | |
OTC Consult
|
0
|
1 year ago | |
Thrombosis Guidelines
|
0
|
1 year ago | |
UKONS
Oncology Initial Guidelines
|
0
|
9 months ago | |
ONCOassist
The go-to app in oncology
|
0
|
3 weeks ago | |
Side Onco Skin
|
0
|
10 months ago | |
Riete Registry
|
0
|
3 weeks ago | |
Compassly: Competency Passport
|
0
|
1 month ago | |
My CML
|
0
|
1 year ago | |
EHA Guidelines
|
0
|
1 year ago |
Cancer iChart Revenue and Downloads
Gain valuable insights into Cancer iChart performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Liverpool Drug Interactions Group
- Languages
- English
- Recent version
- 1.0.1 (11 months ago )
- Released on
- Aug 25, 2018 (6 years ago )
- Also available in
- Australia, United Kingdom, Netherlands, Poland, Japan, South Korea, Kuwait, Kazakhstan, Lebanon, Mexico, Malaysia, Nigeria, Norway, New Zealand, Peru, Philippines, Pakistan, India, Portugal, Romania, Russia, Saudi Arabia, Sweden, Singapore, Thailand, Turkey, Taiwan, Ukraine, United States, Vietnam, South Africa, Dominican Republic, Argentina, Austria, Azerbaijan, Belgium, Brazil, Belarus, Canada, Switzerland, Chile, China, Colombia, Czechia, Germany, Denmark, Italy, Algeria, Ecuador, Egypt, Spain, Finland, France, Greece, Hong Kong, Hungary, Indonesia, Ireland, Israel, United Arab Emirates
- Last updated
- 2 weeks ago